Patent · US Expired

Method for producing a CSAp tryptic peptide and anti-CSAp antibodies

US4468457A · kind A · utility

62Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 1981
Grant dateAug 28, 1984
Priority date
Expiry dateJun 1, 2001

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K39/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A tryptic peptide is produced by partial tryptic digestion of purified, high molecular size colon-specific antigen-p (CSAp), to produce a lower molecular size antigen carrying the CSAp antigenic determinant. The tryptic peptide is used to produce monospecific anti-CSAp antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.